home All News open_in_new Full Article

Cancer survival appears to double with common vaccine, researchers say

A new study finds that combining the COVID vaccine with immunotherapy may nearly double cancer survival rates — patients lived an average of 37.3 months compared to 20.6 months without the vaccine.


today 4 h. ago attach_file Events

attach_file Events
attach_file Events
attach_file Politics
attach_file Events
attach_file Events
attach_file Culture
attach_file Events
attach_file Politics
attach_file Politics
attach_file Sport
attach_file Events


ID: 3771116883
Add Watch Country

arrow_drop_down